Sanofi posts upbeat sales as R&D pressure builds
Apr 23, 2026
Sanofi reported a 6.2% increase in Q1 net sales to 10.5 billion euros, driven by Dupixent demand, despite facing R&D setbacks and leadership transitions.
BioPharma Dive
Show all 12 updates